pharmacie et médicaments – Traitements AMM et hors AMM des malades en dermatologie

This written question concerns the use of approved and off-label medicines for patients with dermatological conditions. It seeks clarification on the regulatory framework and accessibility of these treatments. The question addresses patients, healthcare professionals, and pharmaceutical companies involved in dermatology. It aims to understand how treatment options are managed and what challenges patients may face.